SYNOPSIS Samples of vaginal secretions of 'normal' women were examined over a period of up to two years.
It has been suggested that oral contraceptives predispose some patients to monilial vulvovaginitis (Walsh, Hildebrandt, and Prystowsky, 1965 and 1968; Yaffee and Grots, 1965; Porter and Lyle, 1966) and this complication may be related to the prolonged use of these drugs (Catterall, 1966) .
An attempt to define the extent of this risk was made by studying the vaginal flora of women attending a family planning clinic (Morris and Morris, 1967) . In this population women taking oral contraceptives were not significantly more liable to vaginal candidiasis than other patients, but the limited number of observations prevented us from relating these findings to the duration of hormone treatment.
This paper describes further information obtained by examining these same patients after an interval of one and two years.
MATERIAL AND METHODS
The original population studied was a sequential series of 291 non-pregnant women attending a family planning clinic, most of whom had had one or more pregnancies. One hundred and four of these patients used oral contraceptives at the start of the study and 187 did not. A number of patients who used non-hormonal methods when first examined were subsequently sampled when Received for publication 18 July 1968. using oral contraceptives. A few women stopped taking the pill from personal choice or because they developed a complication. The contraceptive method at the time of sampling is shown in Table I .
The first samples were all collected at the clinic; the later specimens were obtained by visiting the homes of patients living within a 10-mile radius of the clinic. This selection of patients favoured the re-examination of those who were originally taking oral contraceptives, since this method is at present more acceptable and accessible to urban rather than rural dwellers in Wiltshire and Somerset.
To reduce the chance of failing to detect a species when it was present, swabs were collected in triplicate for the first samples and in duplicate for each re-examination.
First samples were inoculated on to media from charcoal-impregnated swabs in Stuart's thioglycollate transport medium within four hours of collection. Later samples, collected at evening domiciliary visits, were maintained at ambient room temperature overnight in transport medium and the culture plates and enrichment broths inoculated the following morning. Earlier experiments on the clinic samples had shown that this delay before inoculating cultures altered the amount of growth but not the number of isolations of C. albicans and fi-haemolytic streptococci.
Candida albicans was isolated by direct plate culture on heated horse blood agar incubated in a candle jar at 37°C and by enrichment culture in 3% glucose broth containing 0-05 mg chloramphenicol per millilitre incubated at room temperature. Plate cultures were 488
Influence of oral contraceptives on the presence and persistence of Candida albicans maintained for 72 hours and broth cultures for seven days. Beta-haemolytic streptococci were isolated by direct plate culture on 10% oxalated horse blood agar and on 1/300,000 crystal violet in horse blood agar incubated anaerobically at 37°C for 18 to 24 hours. Each strain was examined for its ability to hydrolyse aesculin and the Lancefield's serological group determined using the formamide method for extracting the group-specific polysaccharide (Fuller, 1938) .
The selection of the original population studied, the methods of sampling and examining vaginal secretions, and the media used are described more fully in the earlier report. In analysing the results particular regard was taken of two factors. First, in assessing the proportion of patients infected with yeasts or streptococci, the results of 'the last sample collected' have been considered. It is not valid to summate total isolations from total samples since this might bias the results when there are unequal numbers of samples from different patients. Second, when the persistence of C. albicans is considered samples have been included only when patients have remained consistently on the same contraceptive method between two sampling times.
RESULTS
Further samples were collected from 177 of 291 patients originally examined. One hundred and sixtysix women were examined after one year and 99 after two years; this last group included 11 patients who were not sampled one year earlier.
Among the patients who could not be reexamined on one or more occasions, there were 17 who refused, 16 who became pregnant, 30 who did not reply to the domiciliary visit request letter, and 60 who moved away.
On enquiry, no patient gave a history of diabetes and this condition had not been diagnosed on urine analysis during her last preguancy. Urine and blood sugar levels were not determined in the course of this study.
Samples were not all collected at the same point of the menstrual cycle but the isolation rates of C. albicans did not vary significantly with the day of sampling.
INCIDENCE OF C. ALBICANS There was no significant difference in the incidence of C. albicans in first and final samples. Of 291 original samples, 10-7y% contained C. albicans compared with 113 % of 255 final samples from patients with no change in their contraceptivemethod sincethe previous examination.
Isolations from first and final samples were 13-5 % (104 women) and 13.7% (102 women) from women taking oral contraceptives and 9 1 % and 9-8 % from those using alternative methods. (Table II) . PERSISTENCE OF C. ALBICANS Patients with C. albicans on first sampling were significantly more likely to have this organism present in samples collected a year later than were women with no yeasts on the first occasion (Table III) . From a total of 556 samples collected, 65 yielded fl-haemolytic streptococci. These belonged to the following serological groups (number of strains in brackets): A(1), B(35), C(4), D(22), F(1), G(2). Patients with ,B-haemolytic streptococci on one occasion are significantly more likely to have these in the vagina a year later than are women who have no streptococci on first sampling (Table V) . This tendency of patients to retain candida in the vagina for a period exceeding a year was, however, no greater among patients taking oral contraceptives than among other women (Table IV) . The highest incidence occurred in a small group of patients taking Lyndiol/Lyndiol 2-5, the most oestrogenic of the preparations considered here. This incidence was not significantly higher than in other women (P=0-06), but suggests that some preparations may contribute to the development of vaginal candidiasis, a factor which may be confirmed only by studying a larger population. Exact probability P -< 0-001 'Pairs of samples collected at an interval of 10 to 14 months. (Table VI) .
TREATED VAGINAL DISCHARGES IN THE COURSE OF
THIS sTUDY Nine patients, three of whom used oral contraceptives and six of whom did not, were treated by their general practitioner for a vaginal discharge. No microbiological cause was determined, either before or after treatment in five patients. Trichomoniasis occurred in two women, one in association with C. albicans. Two other patients, both using oral contraceptives, had C. albicans after treatment, one patient having been diagnosed before she developed a discharge. There is inconclusive evidence to suggest that strongly oestrogenic oral contraceptives may contribute to the establishment of vaginal candidiasis.
This study has included patients taking combined oral contraceptives only and the results are not necessarily relevant to patients using sequential preparations.
When diagnosing monilial vaginitis, a distinction is made between the presence of a few yeast-like fungi common in the normal vagina and that of numerous blastospores and mycelia characteristic of the disease state (Liston and Cruickshank, 1940; Boycott, 1961 Catterall (1966) , however, found a more rapid response to treatment of established vaginal moniliasis when patients were taken off the pill.
When a patient has symptomatic monilial vaginitis it may therefore be rational to discontinue prescribing a strongly oestrogenic oral contraceptive temporarily but there seems no reason to treat asymptomatic patients prophylactically.
It has been suggested that streptococci of Lancefield's groups B and D are of no aetiological significance in vaginal discharges in non-pregnant women (Morris and Morris, 1967) . Group B streptococci have been associated with fatal endocarditis in pregnancy (Rosenthal and Stone, 1940; Ramsay and Gillespie, 1941) and with meningitis and fulminating pneumonia in the newborn (Rogers, 1968) . Steps must be taken to protect patients with cardiac lesions and infants at term from the risk of infection from these organisms.
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